InvestorsHub Logo
Followers 7
Posts 861
Boards Moderated 0
Alias Born 07/08/2013

Re: None

Saturday, 07/14/2018 8:41:08 PM

Saturday, July 14, 2018 8:41:08 PM

Post# of 14881
To summarize the Libigel situation after reading the little information shared of Jeffq’s discussion with our CEO Pryzbyl . it seems that we can now say that the C camp were the correct thinkers about Libigel. There is no non -disclosure agreement. Libigel is mostly dead but not yet perhaps a funeral. Jon20 had the clear headed view. Pryzbyl called the discussion on this board about Libigel as misguided. That means that the A campers were misguided. I didn’t know that I could of just called the CEO with my questions regarded what was going on with Libigel all these years.

One question remains for me though? Why not inform the shareholders with any information regarding Libigel and the patent claim of 70% reduction in cardiovascular incidence shown in the large safety trial? I guess we can all just call the CEO if we want to know any and all information. Does the medical community care about this?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ANIP News